Pacific Biosciences of California, Inc. (NASDAQ:PACB) will be discussing 3Q20 financial results with the investment community.on 2nd November 2020 at 4:30 PM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.pacb.com
Earnings Expectation
Pacific Biosciences of California, Inc. is reporting third quarter earnings results on Monday 2nd November 2020, after market close.
The consensus estimates from Thomson Reuters are loss of $ 0.13 per share from $ 20.35 million in revenue. For the full year, analysts predict revenues of $ 80.69 million, while looking forward to loss of $ 0.03 per share.
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The companys single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes.
